Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Conclusions:
This study shows that novel chA21 scFv based HER2 specific-CAR T cells not only recognized and killed HER2-positive breast and ovarian cancer cells ex vivo, but also induced regression of experimental breast cancer in vivo. Our data supports further exploration of the HER2 CAR T cell-therapy for HER2-expressing cancers.
Source: Breast Cancer Research - Category: Cancer & Oncology Authors: Meili SunHuan ShiChuanyong LiuJie LiuXianqiang LiuYuping Sun Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Diabetes | Eating Disorders & Weight Management | Endocrinology | Genetics | HER2 | Herceptin | Obesity | Ovarian Cancer | Ovaries | Study